ARNI and SGLT2i: a promising association to be used with caution
J Geriatr Cardiol
.
2020 Nov 28;17(11):728-732.
doi: 10.11909/j.issn.1671-5411.2020.11.005.
Authors
Andrea Herbst
1
,
Francesco Orso
1
,
Marta Migliorini
1
,
Simona Virciglio
1
,
Silvia Tognelli
1
,
Viola Camartini
1
,
Alessandra Pratesi
2
,
Francesco Fattirolli
2
3
,
Niccolò Marchionni
3
,
Andrea Ungar
1
2
,
Samuele Baldasseroni
1
Affiliations
1
Heart Failure Clinic, Division of Geriatric Medicine and Intensive Care Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
2
Department of Experimental and Clinical Medicine, University of Florence, Italy.
3
Department of Cardiothoracovascular Medicine, Azienda Ospedaliero-Universitaria Careggi, Italy.
PMID:
33343652
PMCID:
PMC7729186
DOI:
10.11909/j.issn.1671-5411.2020.11.005
No abstract available
Keywords:
Chronic heart failure; SGLT2i; Sacubitril/valsartan.